Goodwin Procter LLP advised Q32 Bio on the deal. Q32 Bio announced its $60 million Series B financing co-led by OrbiMed Advisors and Acorn Bioventures. Q32…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
